Council for Tobacco Research
Forwarding Memorandum [Discusses Challenges Faced by the Tobacco Industry]
Abstract
MAR
Fields
- Depository Date
- 08 Sep 1997
- Type
- MEMORANDUM
- Box
- 267
- Master ID
- Ctrmn00042811-3384
Related Documents:- CTRMN042811-3094 Deposition of James F. Glenn [Deposition of Glenn in the Matter of the State of Minnesota]
- CTRMN043095-3096 A Frank Statement to Cigarette Smokers [Response to Reports About Link Between Smoking and Lung Cancer]
- CTRMN043097-3103 Agenda Tobacco Industry Research Committee [Includes Information on Advertising and the Link Between Cancer and Smoking]
- CTRMN043113-3118 Background Material on the Cigarette Industry Client [St]
- CTRMN043119-3150 ""Best" Program for C.T.R." [Discusses How the Ctr Serves the Industry]
- CTRMN043151-3153 Statement by Timothy V. Hartrett, Chairman Tobacco Industry Research Committee [Information on Money Given by the Tobacco Industry Research Committee for Specific Scientific Research Projects Into Public Health Problems]
- CTRMN043154-3156 TIRC Program [Information on TIRC]
- CTRMN043157-3157 Hartrett Says Statistics Do Not Establish Causes [Discusses Cause-and-Effect Relationships]
- CTRMN043158-3167 Report on Visit to U.S.A. And Canada 17th April - 12th May 1958 ["Information About Lung Cancer and the Issue of "Causation""]
- CTRMN043168-3190 Survey of Cancer Research with Emphasis on Possible Carcinogens From Tobacco [Increased Incidence of Cancer of the Lung Is Due to Increased Contact with Carcinogenic Stimuli]
- CTRMN043191-3193 Scientist Comments on Benzpirene Report [Discounts the Role of Benzpyrene]
- CTRMN043194-3197 Cancer Scientist's Comments on Smoking-Lung Cancer Review [Discusses Evidence Which Conflicts with the Tobacco-Smoking Theories of Lung Cancer]
- CTRMN043198-3202 the Optimum Composition of Tobacco and Its Smoke [Discussion of Smoke Composition in Relation to Health and Smoking Enjoyment]
- CTRMN043203-3205 Gaps Still Exist in Knowledge of Lung Cancer and Heart Disease, Says Little [States That Many Clinical and Experimental Factors Still Need to Be Identified in Consideration of the Origin of Lung Cancer]
- CTRMN043206-3212 the Smoking and Health Problem--A Critical and Objective Appraisal [Discusses the Cigarette Smoke-Health Problem and the Potential Involvement of the Company's Research Department]
- CTRMN043213-3217 for Release at 6:30 P.M. Monday, February 3, 1969 [Discusses the Lack of A Demonstrated Causal Relationship Between Smoking and Disease]
- CTRMN043218-3223 Visit to Battelle Pacific Northwest Laboratories, Richland, Washington, July 3, 1974 [Discusses the Dog Inhalation Laboratory]
- CTRMN043224-3225 Council Manipulated Media on Smoking's Dangers [Discusses A Report Released by the House Energy and Commerce Health Subcommittee]
- CTRMN043226-3248 the Broadcast Reporting Service Tellex Report A Dying Industry [Discusses the Tobacco Industry As A Lobby]
- CTRMN043249-3258 State of Minnesota County of Ramsey District Court Second Judicial District Case Type: Other Civil Court File No. C1-94-8565 the State of Minnesota, by Humbert H. Humphrey, III, Its Attorney General, and Blue Cross Blue Shield of Minnesota, Plaintiffs, Vs. Philip Morris Incorporated, R.J. Reynolds Tobacco Corporation, B.A.T. Industries P.L.C., Lorillard Tobacco Company, the American Tobacco Company, Liggett Group, Inc., the Council for Tobacco Research -- U.S.A., Inc., and the Tobacco Institute, Inc., Defendants. Response of the Council for Tobacco Research -- U.S.A., Inc. To Plaintiffs' First Set for Requests for Admission [States Ctr's Position on A Number of Questions Regarding Cigarette Smoking As A Cause of Disease]
- CTRMN043259-3260 [Discussion of An Inhalation Project]
- CTRMN043261-3262 Report on Visit to U.S.A. And Canada 17th April - 12th May 1958 Attitude of U.S. Industry to Biological Testing [States That Liggett&Myers Stayed Out of TIRC Because They Doubted the Sincerity of TIRC Motives]
- CTRMN043263-3264 Auerbach's Smoking Beagles [Discusses Response of A Dog to An Inhalation Experiment States That These Methods Produced A Carcinoma in the Animal]
- CTRMN043265-3267 Review of Ctr Abstracts Dated 11/1/70 [Raises Questions About the Relevance of Ctr Grants to the Problem of Smoking and Health]
- CTRMN043268-3270 Auerbach/Hammond Paper [Gives Information on Auerbach's Inhalation Experiments Author Accepts That Significant Tumorogenic Conditions Following Inhalation Have Been Demonstrated]
- CTRMN043271-3274 Supplementary Report on Discussion with Osdene (Philip Morris) [Discussion of Long-Term Mouse Skin Painting]
- CTRMN043275-3276 Statement of F.G. Book in Buffalo, N.Y. On October 12, 1956 [Discusses Laboratory Research on the Subject of Tobacco]
- CTRMN043277-3279 Minutes of Meeting to Discuss Results of Experiments with Smoking Digs Conducted by Dr. Oscar Auerbach - Office of the Council for Tobacco Research, November 3, 1970 [St]
- CTRMN043280-3282 [Accepts Manuscript on Inhalation Studies for Publication]
- CTRMN043283-3285 [Discusses Who Will Serve on the Committee to Study Research Programs Funded by the Tobacco Industry]
- CTRMN043286-3384 [Expresses Frustration with Ctr]
- UCSF Legacy ID
- wot30a00
Document Images
1'
FOf6PAFDING MEFORAMxl1{
0
To Members of the Planning Comnitteet
Attempt has been made to organize this material in such a fashion
that you can get the gist of it all in half an hour, by quick skimming= then
you can go back to study what interests you most.
To reduce the longer enclosutes to mere extracts might omit (through
some blind spot in the mind that tried to edit the material for you) the very
item where you yourself will find the ieportant key to the problem. ,
This is, of course, the most challenging problem our organization
has ever faced - and perhaps the most challenging problem that ever faced a
great industry, one with annual sales of almost $S billions at retail, and
with economic roots that reach clear back to the farm.
The serious nature of the challenge sii=if one, as he explores the
material enclosed. You'll find that some of this information ia confidential,
and requires treatment as such. To have omitted it would have foreshortened
the picture.
Folder ~ contains the lung cancer news in recent magazines and broad,
casts. -- You may have read these pieces separately) but they are wort) re-
reading as a group. Folder 3 contains many pages of inedicai opinions that seem
to exonerate cigarettes from the recent charges made against them, at least in
good part. Folder 4 contains reports on our interviews with four research
directors of major companies. At the Monday night meeting, tearsheets of recent
company advertising will be on hand.
JH 000493
CTR HN 043104

2, ,
The attitude of the men we must directly deal with in the industry
is at once interesting, and important for us, to undezstand. That i-. why notes
on the four interviews with "research directors" are given at some length.
You'll get from them little real information about lung cancer, pro or con; but
you'll find some mighty interesting opinions. One of the men said, "It's for-
tunate for us that cigarettes are a habit they can't break." Said anothers
"Boy: wouldn't it be wonderful if ma company was first to produce a cancer
free cigarette. Whet we could do to competition:" Said another, "Suppose
everybody smoked just one cigarette less a day. That would be maybe 40 bil-
lion a year:" And again, "The stock market fall is terrible, when you remember
dividends are going to be much larger next year without the E.P.T."
At the moment, these men feel thrown for a loop. They've competed
for years - not in price, not in any real difference of quality - but just in
ability to conjure up more hypnotic claims and brighter assurances for what
their own brand might do for a smoker, compared to another brand. And now,
suddenly, they feel all out of bounds, because the old claims become unim-
portant overnight; they are suddenly challenged to produce just one, simple
fact. ?filter Winchell told his own audience the nature of this fact, in brief
wordst "The burden of proof has shifted. It is no longer up to the scientists
to prove that cigarettes cause Idng cancer. It is the duty of all concerned tc
prove that they do not."
And this, of course, is exactly what no individual in theJrrhole worlc
can prove at this juncture; - and until that proof comes in'some form, argu-
ments over the logic of some scientist, and criticism of his particular ideas
of cause-and-effect, can satisfy neither scientists nor public; or get anyMher,
And the days of bright promotion claims, tossed off PLidison Avenue heads like
Lorelei's locks, are suddenly finished.
"This is the way the world ends - not in a bang but a whimper."
JH 000494
u
CTR NN 04310=5

3.
But, naturally, that is something almost too terrible for most of the
industry's men to realize, even yet -- though the very heads of the great corpo-
rations themselves signalized the end of the old days, when they linked arms
and walked together to consult with us.
To work with these men successfully, it is most important for us to
understand a wide range of extraordinary things - so that all of us can reach a
rather new outlook together.
There is only one problem -- confidence, and how to establish itl
.
public assurance, aiid how to create it -- in a perhaps long interim when sci-
entific doubts must remain. And, most important, how to free millions of Ameri
cans from the guilty fear that is going to arise deep in their biological depths
-- regardless of any pooh-poohing logic - every time they light a cigarette.
No resort to mere logic ever cured panic yet, whether on Madison Avenue, Main
Street, or in a psychologist's office. And no mere recitation of arguments pro,
or ignoring of arguments con, or careful balancing of the two together, ia going
to deal with such fear now.
That, gentlemen, is the nature of the unexampled challenge to this
office.
EFD
J
JH 000495
~TR HN 043' 106

4
ProbJ, em 1 t
The very first problem is to establish some public confidence in the
industry's leaders themselves, so that the public will believe their
assertions of their own interest in the public health. Grant Clark
remarked on the telephones "Look at the statements on the Viceroy
package. Look at the Kent advertising. They've been engaging in
that sort of competition for years..You fellows at H and K are in
the middle, and so maybe can do something. Meanwhile, I'm not al-
lowed to send you those ads that were written for Camel. Darr may .
still want to run them, after your own campaign gets started."
(Note here that Darr might use. His exc e for withholding these
ads was the industry's fear of anti-trust action if ideas are too
genezously shared. But that apprehension could readily be clarified,
in this emergency, through having a few frank talks in Washington.
MaFy not our roal problem be the establishing of a complete under-
standing that old patterns of idea-competition are not going to be
perpetuated in this emergency?)
Problem 2s
To reassure the public, and still instinctive fears, in this interim
when definitive facts for giving complete assurance are still lackingi
i
when scientific doubts must remain, and when new "unfavorable" infor-
ssation can emerge from some laboratory at any time, to act as a bomb
shell on the whole tobacco industry -- if it has meanwhile tried to
pooh-pooh the unfavorable finding to date.
JH 000496
C TR- NN 043-10~~'`

r
5
The fact is, of course, that no one who has been a heavy smoker ig
going to benefit himself now by falling into a panic, and elimina-
ting the pleasure and comfort of cigarettes. He might just as .velll
go on enjoying his smoke in this interim while research pursues the
facts,with full assurance that if any cancer-causing agent is ever
really found in tobacco, the manufacturers will quickly find a ra y
to eliminate it.
Problem 3s
How to validate this message of assurance. The men
I
talked to in
the cigarette companies tend tot
(a) Think occasionally in terms of trying to "smear" the per-
sonal responsibility, motives, judgnents, or techniques of
Wynder and others supporting him. (But this approach would
be most dubious.)
(b) To believe the scientific case can be arguing in the public
arena, by leading the layman through elaborate statements which
only specialists are really qualified to weigh and debate, in
their own scientific councils; for the quest of ultimate causes
behind known effects is the specialists' job. (This approach
is shown in the documents from Philip Morris and American
Tobacco, when they extract quotes from the various journals,
and assemble them for public circulation. But it is extremely
doubtful whether anyone could trim such an assembly of quotes
in a'fashion that ra uld (1) give the smoker absolute psycho-
logical assurance, and (2) still leave the compilation a com-
pletely honeststatement of the cancer situation, in a way that
would satisfy most scientists at this juncture. Honesty in
science requires careful consideration and weighing of all
points of view. The cigarette companies cannot hope to spon-J
sor any public debate over cause-and-effect that would satisfy
both smokers and scientists. Hence they are bound to lose in
this effort regardless of what they might briefly gain.)
(c) To overlook the fact that in this particular instance, the
stakes for the public are even larger than for the tobacco esanu-
facturers. (For the public, an issue touching the deepest of
human fears and instincts is involved - the issues of unca ntrol-
lable disease and death. Hence cigarette companies might not
JH 000497
CTR { f N 04-3.f. 08

0
readily be forgiven, if their approach to this problem is
stemmed only from eagerness to protect their earnings, and
if they twisted the research of medical science (which seeks
to save men) into a device to save stockholders. There is
no precedent where a great industry has been forced to face
such grave issues.
In the past, industry has given little twists to the facts
of science, to convert them into sales propaganda, without
much risk. The cigarette industry has indeed been doing
this for years. We can therefore readily understand its
assumptions that the same technique will work now, in de-
vising propaganda. But it is highly impcrtant ', note that
the deep issues of life-and-death that are now involved
make highly doubtful the question as to whether the familiar
techniques can be relied on. The stakes are too large; the
penalties for losing could be too great.)
(d) To assume that agents like science writers can be
guided and encouraged to disseminate special "interprete-
tions" of current findings,in ways that would blame lung
cancer on everything else but cigarettes - or (even better)
in ways that nould throw doubt on the validity of tatis-
tics shDwing great increases in lung cancer. If the issue
were merely coughs, or sore throats, or warts, this might
rb rk. There is serious question as to whether anyone --
after due reflection -- would consider such a course use-
ful for long term purposes, in the present circumstances.
c.
0
r
.
Problem 41
We must early decide our own attitude toward the findingeof men
like Wynder, Rhoads, Ochsner, et al. We have a choice, as previously
indicated, ofs
(a) Smearing and belittling them;
J
(b) Trying to overwhelm them rd th mass publication of the
opposed viewpoints of other specialists;
(c) Debating them in the public arena; or
(d) We can determine to raise the issue far above them. so
that they are hardly even mentioned; and then we can make our
real case.
JN 000498
Cf R Hf'i 04' 3109.

7
Pr9blem 5l
.
Problem 5 hitches on to Problem 4 and all subsequent problems.
How can we move immediately to identify the tobacco companies com-
pletely with concern for the public good? This accomplishment -- if
we can manage it -- would throw everything else into proper focus,
and would show the answers to the other various problems.
Problem 6i
There is much to indicate that we have one essential job - whichcan
be simply said:
Stop public panic, without ever getting in the position of
giving false assurances, or of giving false emphases.
The facts for the average man are reassuring enough, without
getting into any scientific arguments whatevers his chances
of getting lung cancer are too infinitesimal to worry about
at all, in this moment of scientific uncertainties. Some
22,000 people in the U. S. will die of lung cancer this year -
that's 22,000 too many. Let any man give up smoking cigarettes
if he wants to. But the average man is lots more likely to die
by an automobile accident (some 36,000 deaths annually); or of
tuberculosis (some 24,000 deaths annually); or of heart disease
(over half a million deaths annually). So let the scientists
do the rro rrying for us - that's their business; and meanwhile
let us go on eating, and working, and playing, and smoking,
and relaxing, and riding in automobiles, and living a good
life everyday.
You can count on the cigarette companies (who have obligated
themselves to pour millions of dollars into cancer research)
to take anything out of your cigarette that is a health
hazard, if our science ever really finds any such hazard in ~
the wonderful tobacco leaf. Meanwhile kno)r thist despite
the moat elaborate attempts, no efforts to give mice a lung
illness by making them }ixe days on end in tobacco smoke
have ever produced a case of such illness through that kind
of exposure.
JH 000499
V' I I 1 I ll yl 043110

rI
Soma Things to Do
The items on this page comprise quick suggestions by various
members of the organization, starting with bo. Goss. They are intended as
suggestions for debate, and for stimulating otherss
1. Name for Committee?
2.
3.
4.
5.
9.
A basic Credo Statements "We place health firstj we have long
been seeking the factsi we are financing more research, seek-
ing still more facts." ??ien -- consider exactly what view-
point and attitude industry will universally adopt toward
unfavorable research reports.
Explore advisability of having made a truly scientific
summary review, and analysis of the facts, as these
are recognized by the majority of our best researchers
and research institutions at this time. Could National
Cancer Institute do?
Consider authoritative brief digest (5-10 pages) of
"favorable" scientific reports, to go with full texts
of the same reports to science and magazine writers,
cigarette salesmen, iroportant magazines and syndicates.
Could National Cancer Institute authenticate?
Decide whether we suggest company publicity or adver-
tising. Consider what the chief points in such
messages should be. Decide how this advertising could
be coordinated, so that it doesn't bog down a competitive
dog fight. Decide what any one company could say, that
couldn't be better said by all companies jointly -- when
they honestly face a problem of human import where com-
petition has no place.
.
6. Start screening and planning a scientific research program
by research coamittee.
7. Select an agency to plan institutional advertising to
(a) doctors and (b) public. Consider what kind of inessages/
you want to get across.
8. Get research data on excessive smoking, if definable; on
smoking by sex, age, region, urban and rural districts.
Develop some understanding with companies that, on JhU
problem, none isgoing to seek a competitive advantage
by inferring to its public that j,Ls product is less risky
than others. (No claims that special filters or
JH 000500
,
... ........,..
CTR r"N 043111

(
Some Things to Do (Continued)
toasting, or expert selection of tobacco, or extra length
in the butt, or anything else, makes a given brand less
likely to cause you-know-what. No "Play-Safe-with-Luckies"
idea - or with Camels or with anything else.)
1Q. Consider how appropriations for cancer research by industry
could be most effectively handled -- not alone*from view-
point of research institutions, but also from viewpoint of
how this occasion can contribute to building public con-
fidence in the integrity of,the industry's leaders.
11. Consider whether publicity on this subject (after its tenor
is established under Point 2) should all emanate from one
central sourcej and if not, how the various companies can
avoid the risk of having all efforts at confidence building`
spoiled -- Just because some bright boy on Madison Avenue
reverted some morning to his old techniques.
J
JH 000501
t.x f R f f N 043112
